1-3 of 3
HoYoung Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Velcade ® , Thalidomide, Dexamethasone (VTD) Followed by Melphalan, Prednisone, Thalidomide (MPT) Maintenance as a First Line Treatment Demonstrates High Response Rates for High-Risk Patients with Multiple Myeloma (MM) Who Are Non-Transplant Candidates: Updated Results of Phase II Trial

HyeonSeok Eom, Yeo-Kyeoung Kim, Joo-Seop Chung, Kihyun Kim, Hyo-Jung Kim, HoYoung Kim, Jong-Youl Jin, Young-Rok Do, Suk-Joong Oh, Cheolwon Suh, Chu-Myong Seong, Chul Soo Kim, Dong Soon Lee, Jae Hoon Lee
Journal: Blood
Blood (2008) 112 (11): 2785.
https://doi.org/10.1182/blood.V112.11.2785.2785
Published: 2008
Journal Articles

Velcade®, Thalidomide, Dexamethasone (VTD) Induction Therapy Followed by Melphalan, Prednisone, Thalidomide (MPT) Maintenance as a First Line Treatment for the Patients (pts) with Multiple Myeloma (MM) Who Are Non-Transplant Candidates: Early Analysis from the Korean Multiple Myeloma Working Party.

HyeonSeok Eom, Yeo-Kyeoung Kim, Jooseop Chung, Kihyun Kim, HyoJeong Kim, JongYul Jin, Young-Rok Do, Sukjoong Oh, HoYoung Kim, Cheolwon Suh, Chu-Myong Seong, Chul Soo Kim, Dong Soon Lee, Jae Hoon Lee
Journal: Blood
Blood (2007) 110 (11): 4831.
https://doi.org/10.1182/blood.V110.11.4831.4831
Published: 2007
Journal Articles

A Multicenter Phase II Trial of Etoposide, Methylprednisolone, High-Dose Cytarabine, and Oxaliplatin (ESHAOx) for Patients with Refractory/Relapsed Aggressive Non-Hodgkin’s Lymphoma.

Sun Jin Sym, MD, Hye Jin Kang, M.D., Seung-Hyun Nam, M.D., Hoyoung Kim, M.D., Seok Jin Kim, M.D., Hyeon Seok Eom, M.D., Won Seog Kim, M.D., Cheolwon Suh, M.D.
Journal: Blood
Blood (2007) 110 (11): 3446.
https://doi.org/10.1182/blood.V110.11.3446.3446
Published: 2007